Julie Xing

Julie Xing is a seasoned executive with extensive experience in leadership roles across the pharmaceutical and biotechnology industries. Currently serving as a Member of the Board of Directors at Aptar and Mars, and as the Executive Chair of China at Mundipharma, Julie brings valuable insights to these prominent organizations. Previously, Julie was the Global Senior Vice President and President of Greater China at Envista Holdings Corporation. Julie's prior experience at Eli Lilly and Company spanned various senior director positions and involved market access and pricing strategy. Additional experience includes leadership roles at Affymetrix and Illumina in the Asia Pacific region. Julie holds a Doctor of Philosophy (Ph.D.) in Biology/Biological Sciences from The Hong Kong University of Science and Technology.